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Abstract
Background: Type D personality has been associated in the past with increased cardiovascular mortality among
patients with established coronary heart disease. Very few studies have investigated the association of type D
personality with traditional cardiovascular risk factors. In this study, we assessed the association between type D
personality and the metabolic syndrome.
Findings: New consecutive patients referred to an outpatient lipid clinic for evaluation of possible metabolic
syndrome were eligible for inclusion in the study. The metabolic syndrome was defined according to the
International Diabetes Federation (IDF) diagnostic criteria. Type D personality was assessed with the DS-14 scale.
Multivariate regression techniques were used to investigate the association between personality and metabolic
syndromes adjusting for a number of medical and psychiatric confounders. Three hundred and fifty-nine persons
were screened of whom 206 met the diagnostic criteria for the metabolic syndrome ("cases”) and 153 did not
("control group”). The prevalence of type D personality was significantly higher in the cases as compared to the
control group (44% versus 15% respectively, p < 0.001). In multivariate logistic regression analysis the presence of
Type D personality was significantly associated with metabolic syndrome independently of other clinical factors,
anxiety and depressive symptoms (odds ratio 3.47; 95% Confidence Interval: 1.90 - 6.33).
Conclusions: Type D personality was independently associated with the metabolic syndrome in this cross-sectional
study. The potential implications of this finding, especially from a clinical or preventive perspective, should be
examined in future research.
Introduction
Over the recent years, there is a growing interest of the
impact of various psychosocial factors in cardiovascular
morbidity and mortality [1]. Several prospective studies
suggested that common mental disorders, such as
depression and anxiety, may be associated with an
increased risk of cardiovascular events in either healthy
persons or patients with coronary heart disease (CHD)
[1]. Similarly psychosocial factors, such as enhanced ‘job
strain’ as well as the lack of social support, have been
proposed as risk factors for CHD. In this context, it is
also noted that specific patterns of personality character-
istics have been found to independently predict CHD
morbidity and mortality [1].
Type D personality is a relatively new personality con-
struct which is characterized by two global personality
traits: negative affectivity and social inhibition [2]. Per-
sons exhibiting this type of personality are inclined to
experience negative emotions which are further asso-
ciated with the tendency to inhibit these emotions by
avoiding social contacts [2]. These personality traits
h a v eb e e nf o u n dt ob er e l a t i v e l ys t a b l eo v e rt i m ea n d
lead to chronic emotional stress [3,4]. They are distin-
guished from depression or anxiety which is more episo-
dic in nature and tends to change over time [3].
Prospective studies have suggested a potential associa-
tion of type D personality with poor prognosis and
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CHD [2,3,5].
Evidence of underlying mechanisms to clarify the rela-
tionship between type D personality and the pathogen-
esis of CHD is just beginning to emerge [1]. Some
studies suggested that type D personality may be asso-
ciated with increased inflammation and enhanced corti-
sol secretion in response to stress, and these may
increase the risk for cardiovascular morbidity[6-8].
Furthermore, individuals with type D personality may
also suffer from co-morbid depressive and/or anxiety
disorders that may account for worse prognosis in
patients with CHD [9].
The metabolic syndrome (MetS) comprises the clus-
tering of traditional cardiovascular risk factors, including
obesity, hypertension, dyslipidemia and hyperglycemia
[10]. Longitudinal studies have shown that patients with
the metabolic syndrome may exhibit greater cardiovas-
cular morbidity and mortality as compared to persons
who do not fulfill the diagnostic criteria of the metabolic
syndrome [10]. Since MetS can increase the risk of sub-
sequent CHD [10] it would be important to investigate
whether the type D personality is also associated with
such preliminary stages of disease as the possibility of
primary prevention may be more feasible at that time.
In a recent community study in the Netherlands [11] an
association was reported between type D personality
and the metabolic syndrome but the latter was assessed
using a self-report questionnaire. In addition type D per-
sonality has been associated with some components of
the MetS (such as hypertension in women and hyperch-
olesterolemia in men) in a general population sample
from Germany [12].
The main aim of the present study was therefore to
investigate whether the prevalence of type D personality
was higher in patients with the MetS as compared to a
control group of persons not fulfilling the criteria for
MetS. A variable that could potentially confound this
association is the presence of episodic distress (mainly
in the form of depressive and anxiety symptoms) since
this is known to be associated with both type-D person-
ality and the risk for CHD [13,3]. Therefore our second-
ary aim was to test the hypothesis that the association
between type-D and the MetS would be independent of
the presence of anxiety or depressive symptoms.
Methods
Study population
This cross-sectional study was conducted in Ioannina, a
major university city of the Northwestern part of
Greece. New consecutive patients with a presumptive
diagnosis of MetS referred to the Outpatient Lipid
Clinic of the University Hospital of Ioannina (the refer-
ral centre for the broader region of Epirus with 300,000
inhabitants) from April 2007 to January 2009 were eligi-
ble for inclusion to the study. Participants were
excluded if they had significant medical or psychiatric
comorbidities. These included coronary heart disease,
types 1 or 2 diabetes, thyroid disorders, severe hepatic
or renal diseases. All included persons gave a written
informed consent. The study protocol was approved by
the Ethics Committee of the University Hospital of
Ioannina.
Clinical evaluation
According to the study protocol, at the first visit of each
subject in the Outpatient Lipid Clinic, the following
parameters were evaluated: i) anthropometric indices
[BMI, waist circumference], ii) smoking habits, iii) blood
pressure readings, iv) routine laboratory measurements
including fasting blood glucose and serum lipid profile.
Waist circumference was measured by placing a tape
in a horizontal plane around the abdomen between the
lower rib and iliac crest. The tape should have been
snug without compressing the skin and parallel to the
floor. Measurements were taken at the end of a normal
expiration by the same investigator. Blood pressure was
measured in triplicate, following ten minutes rest, at
each visit. Measurements were carried out by trained
physicians in the sitting position using a standard vali-
dated automated sphygmomanometer. The first reading
was discarded and the mean of the second and third
readings was used for the analysis.
Participants were asked a series of questions about
their smoking habits. They were first asked a question
about lifetime smoking and then about their smoking
status during the past month. Persons who smoked dur-
ing the past month were also asked the average number
of cigarettes smoked per day (grouped in less than 10,
10-20, more than 20 per day). For our analysis, all parti-
cipants who admitted having smoked during the past
month were considered current smokers and the
remaining non-smokers.
Height and body weight were measured with partici-
pants standing without shoes and heavy outer garments.
Body mass index (BMI) was calculated as weight divided
by height squared (kg/m
2).
Laboratory investigations
All laboratory measurements were performed at the Bio-
chemistry Laboratory of the University Hospital of Ioan-
nina, by standardized methods using an Olympus
AU600 clinical chemistry analyzer (Olympus Diagnos-
tica, Hamburg, Germany), as described previously [14].
Blood samples were obtained following a 14-hour over-
night fast. The concentrations of total cholesterol and
TG were determined enzymatically on the Olympus AU
600 clinical chemistry analyzer. HDL-cholesterol was
Tziallas et al. BMC Research Notes 2011, 4:105
http://www.biomedcentral.com/1756-0500/4/105
Page 2 of 8determined by a direct assay[14]. Low-density lipopro-
tein (LDL)-cholesterol was calculated using the Friede-
wald formula. Blood glucose was measured by the
hexokinase method [14].
Diagnosis of Metabolic Syndrome
Metabolic syndrome was defined according to the Inter-
national Diabetes Federation (IDF) definition for Eur-
opean populations using the following criteria:
- presence of central obesity, as defined either by waist
circumference ≥ 94 cm in men or ≥ 80 cm in women or
by body mass index (BMI) > 30 mg/m
2, plus two of the
following criteria: i) triglyceride (TG) levels ≥ 150 mg/
dL, or specific treatment for this lipid abnormality ii)
high-density-lipoprotein (HDL)-cholesterol levels < 40
mg/dL in men and < 50 mg/dL in women, or specific
treatment for this lipid abnormality iii) fasting plasma
glucose ≥ 100 mg/dL (≥ 5.6 mmol/L) or previously diag-
nosed type 2 diabetes, and iv) systolic blood pressure ≥
130 mmHg or diastolic blood pressure ≥85 mmHg or
treatment for previously diagnosed hypertension. The
diagnosis of hyperglycemia and dyslipidemia was based
on the average of two measurements taken at least two
weeks apart. If there was a 15% or greater difference
between blood glucose or lipid measurements a re-eva-
luation visit was scheduled and the mean value of the
first visit and re-evaluation visit measurements was used
for the determination.
According to the above mentioned definition, our
population was divided into those persons who fulfilled
the diagnostic criteria for the MetS (MetS group; cases)
and those who did not fulfill the criteria for the diagno-
sis of the MetS (control group; controls). A total of 359
persons (206 individuals who fulfilled the diagnostic cri-
teria for the MetS [cases] and 153 individuals who did
not meet the criteria for the diagnosis of the MetS [con-
trols]) were included in the present study.
Assessment of type D personality
All participants completed the Type D Scale-14 (DS14)
which is designed to assess the Type D personality [4].
Type D refers to the tendency to simultaneously
(i) experience negative emotions and (ii) inhibit self-
expression in social interaction, and may predispose to
chronic emotional distress. Accordingly, the DS14 com-
prises a 7-item subscale measuring negative affectivity
(tendency to experience negative emotions as the first
component of Type D) and a 7-item subscale measuring
social inhibition (tendency to inhibit self expression as
the second component of Type D). Each item is mea-
sured on a 5-point Likert scale ranging from 0 to 4 and
each subscale can have a range of scores of between 0
and 28. The Greek version of the DS14 was translated
using the procedure recommended by the World Health
Organization http://www.who.int/substance_abuse/
research_tools/translation/en/index.html.
As this is the first time this scale is used in Greece, in
the current paper we also present data on its psycho-
metric properties. The internal consistency of the overall
scale was very good with a Cronbach’sa l p h ao f0 . 8 6 .
The Cronbach’s alpha for the two subscales was 0.79
and 0.81 for social inhibition and negative affectivity
respectively. The item-total correlations had a range
between 0.44 - 0.77 for the social inhibition sub-scale
and 0.51 - 0.79 for the negative affectivity sub-scale.
These figures are very similar with those reported by
Denollet in his original validation of the DS14 in a
Dutch sample [4]. An exploratory factor analysis of the
14 items was performed using the principal factor
method in Stata. As found in the original validation [4]
there were two main factors with eigenvalues of 5.36
and 1.54 explaining 49% of the variance. After a promax
rotation allowing for oblique factors seven items loaded
on the negative affectivity factor with a loading ranging
between 0.56 to 0.70 and seven on the social inhibition
factor with a loading ranging from 0.51 to 0.75. All
items loaded on their corresponding trait factor as
found in the original validation in the Dutch sample [4].
In addition all items had a loading on the other factor
which was less than 0.33 (corresponding to <10% of
overlapping variance) and the minimum difference
between the two loadings was at least 0.20. The two fac-
tors were moderately correlated with r = 0.34. The full
results of the internal consistency analysis and the factor
analysis are available from the authors.
Participants were classified as showing a type D per-
sonality using the criteria suggested in the original vali-
dation study [4]. That is, participants who had a score
on both sub-scales above the median were classified as
Type D positive. The empirically derived cut-off scores
used in the present study were >13 for negative affectiv-
ity and >10 for social inhibition.
Assessment of Anxiety and Depressive symptoms
Anxiety and depressive symptoms were assessed by a
validated Greek version of the Hospital Anxiety and
Depression Scale (HADS) [15]. The HADS is a brief
self-assessment scale assessing the two most common
aspects of psychological distress found in hospital set-
tings: anxiety and depression [16]. The scale consists of
14 items, seven for each subscale, and each item is rated
on a four-point (0-3) scale. The scoring system ranges
from the absence of a symptom or the presence of posi-
tive features (scoring 0) to the maximal presentation of
symptoms or the absence of positive features (scoring
3). There is no single generally accepted cut-off score
for the HADS, especially for the population of the cur-
rent study. For this reason, in the present study we used
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th percentile as an arbitrary cut-off to denote
clinically significant symptomatology. The 75
th percen-
t i l ew a st h es c o r eo f7f o rt h ed e p r e s s i o ns u b s c a l ea n d
the score of 10 for the anxiety subscale and therefore all
those scoring above (and not including) this cut-off
were considered as “cases” of depression or anxiety
respectively.
Statistical analysis
Preliminary analysis was per f o r m e dt oe n s u r en ov i o l a -
tion of the assumptions of linearity and normality. The
Shapiro-Wilk test was used to evaluate whether each
parameter followed a Gaussian distribution. Data were
expressed as mean ± SD, except for non-Gaussian para-
meters, which were presented as median (range).
A comparison of continuous variables was performed by
an unpaired two-tailed Student’s t-test for normally dis-
tributed variables and a Mann-Whitney test for non-
normally distributed variables, while chi
2-tests were
used for categorical variables.
The strength of associations of clinical parameters,
anxiety and depressive symptoms as well as type D
personality with the MetS were assessed by means of
logistic regression analysis, comparing persons who met
the diagnostic criteria for the MetS and those who did
not meet the criteria for the diagnosis of the MetS.
These associations were first tested in univariate analy-
sis. Multivariate analysis was then performed by binary
logistic regression analysis, which allows adjustment for
all potential confounding factors, including demo-
graphic, clinical parameters as well as the presence of
anxiety or depressive symptoms. Significance levels were
set at p < 0.05 in all cases. Stata version 9.0 was used
for the analysis (StataCorp, College Station, Texas).
Results
Prevalence of type D personality, anxiety and depressive
symptoms
Baseline demographic, clinical and laboratory characteris-
tics of the study population are shown in Table 1. Pre-
sence of anxiety and depressive symptoms above the cut-
off were more common among individuals with MetS as
compared to controls (Table 1). The prevalence of type D
personality was significantly higher in individuals with the
MetS compared with controls (44% versus 15%, in cases
with the MetS and controls, respectively, X
2
(1)= 33.43, p <
0.001). Each component of type D personality, social inhi-
bition and negative affectivity, was more prevalent in the
MetS group than in the control group (Table 1).
Association between type D personality and the
metabolic syndrome
In univariate analyses, Type D personality was strongly
associated with the presence of MetS (odds ratio: 4.39;
95% confidence interval: 2.60 - 7.39, see Table 2). Both
components of this type of personality (i.e. negative
affectivity and social inhibition) resulted in significant
association with the presence of MetS. Persons with
depressive and anxiety symptoms above the cut-off were
more likely to be cases of the MetS (Table 2).
Results of the multivariate analysis are shown in Table 3.
The presence of Type D personality was significantly asso-
ciated with MetS independently of clinical factors, anxiety
and depressive symptoms (odds ratio: 3.47; 95% CI: 1.90-
6.33, see Table 3, model 1). We then examined the two
sub-components of type D personality (i.e. negative affec-
tivity and social inhibition), which were entered to the
model as independent variables instead of type D person-
ality (Table 3, model 2). In this analysis, both sub-compo-
nents resulted in a significant association with the MetS
independently of other clinical and psychological factors
(Table 3, model 2). Presence of depressive symptoms
above the cut-off also showed evidence of independent
statistical association with MetS in the multivariate analy-
sis in contrast to presence of anxiety symptoms above the
cut-off which was not significant in the adjusted model.
We also tested for an interaction between Type D person-
ality and presence of depressive symptoms above the cut-
off but the interaction term was not significant (likelihood
ratio test = 0.32 on 1 degree of freedom, p = 0.57).
Association between type D personality and the
components of the metabolic syndrome
Table 4 shows the association between type D personal-
i t ya n dt h es e p a r a t ec o m p o n e n t so ft h em e t a b o l i cs y n -
drome. In the adjusted analyses, fasting blood glucose
≥100 mg/dl) and higher TG levels were found to be sig-
nificantly associated, while higher blood pressure was
marginally non-significant.
Discussion
In a population attending a university-based outpatient
lipid clinic, we found that type D personality was signifi-
cantly associated with a diagnosis of metabolic syn-
drome. Of interest, this association remained even after
adjustment for potential confounding factors, including
demographic and clinical parameters as well as the pre-
sence of anxiety and depressive symptoms. Multivariate
analysis revealed that both components of type D per-
sonality resulted in an independent association with the
presence of metabolic syndrome. On the other hand, the
particular diagnostic components of the metabolic syn-
drome associated with type D personality were fasting
blood glucose ≥100 mg/dl and TG levels ≥ 150 mg/dl.
Our results must be interpreted in the light of certain
limitations. Namely, in the context of our cross-sectional
study it was not possible to examine the temporal asso-
ciation between type D personality and MetS. Although
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do not have data on the stability of this construct and
the possibility of reverse causality cannot be ruled out.
Longitudinal studies should explore further this issue.
There is also the possibility of measurement errors,
especially in the assessment of psychiatric symptoms.
The latter were crudely assessed with a simple self-
reported instrument and there is the possibility of mis-
classification. However, this will be most likely of a ran-
dom nature and a systematic error is unlikely. Similarly,
the assessment of type D personality is based on a
simple self-reported instrument. In addition, the type D
construct is a relatively recent one and its usefulness
and stability over time remain to be established for a
range of medical conditions. Finally, in our analyses we
did not adjust for lifestyle factors (exercise and diet) and
family history of CHD in first degree relatives as these
variables were not available.
To date, previous observational studies suggest that
type D personality may be related with worse outcomes
in patients with established atherosclerosis, including
CHD or peripheral artery disease [2,3,17]. Namely,
Table 1 Demographic, clinical/laboratory and psychological features of 359 attenders of an outpatient lipid clinic by
metabolic syndrome case status
Cases of Metabolic Syndrome (N = 206)
Mean (SD/Range) OR N (%)
Control Group (N = 153)
Mean (SD/Range) OR N (%)
Age, years 58 (11) 50 (12)**
Male, N (%) 93 (45) 81 (53)
Current smokers, N (%) 43 (21) 39 (26)
BMI, kg/m
2 30 (6) 26 (4)**
Systolic BP, mm Hg 140 (15) 125 (14)**
Diastolic BP, mm Hg 86 (9) 80 (9)**
Waist circumference, cm 104 (10) 93 (11)**
Fasting blood glucose, mg/dL 107 (17) 93 (11)**
Total cholesterol, mg/dL 235 (51) 207 (40)**
TG, mg/dL 189 (45-934) 122 (34-389)**
HDL-C, mg/dL 49 (13) 52 (14)*
LDL-C, mg/dL 148 (47) 130 (37)**
Psychological Variables
Type D personality, N (%) 90 (44) 23 (15)**
Social inhibition criteria, N (%) 124 (60) 49 (32)**
Negative affectivity criteria, N (%) 123 (60) 41 (27)**
Depressive symptoms above the cut-off, N (%) 67 (33) 22 (14)**
Anxiety symptoms above the cut-off, N (%) 60 (29) 27 (18)*
-Abbreviations: BMI, body mass index; BP, blood pressure; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol;
*p < 0.01 for the comparison between groups, **p < 0.001 for the comparison between groups; Values are expressed as mean (standard deviation) [except TG-
median (range)] for continuous variables and number (percentage) for categorical variables.
Table 2 Crude (unadjusted) odds ratios for fulfilling criteria for metabolic syndrome in 359 attenders of an outpatient
lipid clinic
Odds ratio (95% CI) p
Components of the Metabolic Syndrome* (European IDF definition)
High fasting blood glucose (≥100 mg/dl) 11.62 (6.90-19.57) <0.001
Low HDL-C (<40 mg/dl in ♂ or <50 mg/dl in ♀) 2.44 (1.53-3.91) <0.001
High TG (≥ 150 mg/dl) 8.93 (5.42-14.72) <0.001
High BP (≥ 130/85 mmHg) 7.60 (4.62-12.48) <0.001
Psychological Variables
Type D personality 4.39 (2.60-7.39) <0.001
Negative affectivity sub-component of type D personality 4.05 (2.57-6.37) <0.001
Social inhibition sub-component of type D personality 3.21 (2.07-4.98) <0.001
Depressive symptoms above the cut-off 2.87 (1.68-4.91) <0.001
Anxiety symptoms above the cut-off 1.92 (1.15-3.20) 0.01
*Please note that increased waist circumference has been omitted because by definition all cases met this criterion. Abbreviations: IDF: International Diabetes
Federation; TG: triglyceride; BP: blood pressure; HDL-C: high-density lipoprotein cholesterol; CI, confidence intervals.
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exhibit type D personality are more likely to suffer from
a major cardiac event, corresponding to cardiac death,
myocardial infarction and cardiac revascularization pro-
cedures as compared to those who do not exhibit this
type of personality [3]. In addition to that, a recent
report suggested that type D personality may serve as an
independent predictor of all-cause mortality among
patients with peripheral artery disease [17]. Further-
m o r e ,i th a sb e e ns h o w nt h a tt h i st y p eo fp e r s o n a l i t y
may be associated with impaired health status and
increased mortality rate in patients with chronic heart
failure [18,19]. Another example of this kind of psycho-
somatic association is that anxious patients with implan-
table cardiac defibrillator who exhibit type D personality
are more susceptible to suffer ventricular arrhythmias
[20].
Another important clinical and research point is to
identify mechanisms to explain this potential association
between type D personality and the pathogenesis or the
progression of atherosclerotic vascular disease. Several
studies demonstrated a link between type D personality
and biomarkers which may increase cardiovascular risk.
For instance, persons with type D personality may exhi-
bit higher circulating levels of several pro-inflammatory
cytokines, including tumor necrosis factor-a (TNA-a)
and its soluble receptors 1 and 2. These cytokines are
known to be contributors in the pathogenesis of CHD
as well as predictors of mortality among patients with
CHD [6]. Furthermore, an elevated cortisol secretion in
response to stress as well as higher cortisol output, as a
result of a prolonged disruption of adrenal-pituitary axis
function, was noted among persons with type D person-
ality [21,22]. Morning cortisol secretion was noted to
positively correlate with significant coronary artery ste-
nosis in women having survived an acute coronary syn-
drome [23]. It is important to appreciate that type D
personality may increase cardiovascular risk by favoring
behavioral patterns including an unhealthy lifestyle as
well as poor compliance to treatment [24].
To date, there are no sufficient data to establish an
association between type D personality and ‘traditional’
cardiovascular risk factors. In this study, a strong and
independent association was demonstrated between this
Table 3 Adjusted odds ratios for fulfilling criteria for metabolic syndrome in 359 attenders of an outpatient lipid
clinic*
Model 1 Model 2
Odds ratio (95% CI) p Odds ratio (95% CI) p
Type D personality 3.47 (1.90-6.33) <0.001 NA NA
Negative affectivity sub-component of type D personality NA NA 2.75 (1.56-4.83) <0.001
Social inhibition sub-component of type D personality NA NA 2.03 (1.20-3.45) 0.009
Depressive symptoms above the cut-off 2.59 (1.36-4.94) 0.004 2.14 (1.10-4.13) 0.02
Anxiety symptoms above the cut-off 0.98 (0.51-1.89) 0.95 0.89 (0.46-1.72) 0.72
Smoking status 1.35 (0.72-2.52) 0.34 1.42 (0.75-2.67) 0.28
Age 1.04 (1.01-1.07) 0.02 1.04 (1.01-1.07) 0.02
*Variables included in models: Age, gender, marital status, educational status, employment status, household income, smoking status, anxiety symptoms above
cut-off, depressive symptoms above cut-off and type D personality (model 1) or sub-components of type D personality [negative affectivity and social inhibition]
(model 2).
Abbreviations: CI, confidence interval; NA, not applicable.
Table 4 Association between Type D personality and the various components of the metabolic syndrome in 359
attenders of an outpatient lipid clinic
Dependent Variable:
Component of the Metabolic Syndrome
Independent Variable:
Type D Personality
(European IDF definition) Crude Odds ratios
(95% CI)
p Adjusted Odds ratios*
(95% CI)
p
Increased waist circumference
(≥94 cm in ♂ or ≥80 cm in ♀)
2.43 (1.18-5.01) 0.02 1.71 (0.73 - 3.99) 0.21
High fasting blood glucose (≥100 mg/dl) 2.53 (1.59 - 4.00) <0.001 2.13 (1.23-3.66) 0.006
Low HDL-C (<40 mg/dl in ♂ or <50 mg/dl in ♀) 1.22 (0.76 - 1.95) 0.41 1.36 (0.78-2.35) 0.27
High TG (≥ 150 mg/dl) 2.19 (1.38-3.45) 0.001 2.17 (1.28 - 3.68) 0.004
High BP (≥ 130/85 mmHg) 2.54 (1.50-4.29) 0.001 1.76 (0.97-3.19) 0.06
Odds ratios from separate logistic regression models with each of the components of the metabolic syndrome as the dependent variable and Type D personality
as the independent variable. *Odds ratios adjusted for: Age, gender, marital status, educational status, employment status, household income, smoking status,
anxiety symptoms above cut-off and depressive symptoms above cut-off. Abbreviations: IDF: International Diabetes Federation; CI: confidence intervals.
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tant state which comprises a clustering of traditional
cardiovascular risk factors, including elevated blood
pressure and TG levels, low concentration of HDL-
cholesterol as well as impaired fasting glucose [10].
Therefore, MetS should be considered an early stage in
the pathway of atherosclerotic vascular disease progres-
sion [10]. Our results may provide an additional
mechanism to explain adverse cardiovascular outcomes
among persons who exhibit this type of personality.
Since the concept of type D personality is relatively
new, few assumptions could be made to explain a poten-
tial association between this type of personality and
MetS. As described previously, type D personality has
been associated with a prolonged disruption of adrenal-
pituitary axis function [23]. Hypothalamus-pituitary-
adrenal axis dysregulation, resulting in elevated cortisol
levels, has been associated with hypertension, hyperlipi-
demia and insulin resistance, which are the main compo-
nents of MetS [25]. Furthermore, there is tendency of
persons with type D personality to experience anxiety or
depressive symptoms which are both associated with
MetS [26-28]. The high prevalence of these psychiatric
disorders in individuals with type D personality, also
observed in our study, may be of help to explain the asso-
ciation between type D personality and the MetS. This
may hold true considering that negative health behaviors
as well as hypothalamic and sympathetic dysregulation
related to these psychological disorders may increase the
risk for the development of the MetS, particularly for its
components of central adiposity and insulin resistance
[26]. Consistently, according to our univariate analysis,
type D personality was significantly associated with fast-
ing blood glucose and waist circumference measurements
(although the latter was reduced after adjustment, see
Table 4). Therefore, it couldb eh y p o t h e s i z e dt h a tt h e
association between type D personality and MetS may be
mediated through the enhanced prevalence of anxiety or
depressive symptoms in type D personality (also evident
in our study). However, in our multivariate analysis, type
D personality was found to be the most significant pre-
dictor of MetS independently of the presence of either
anxiety or depressive symptoms. It should be noted how-
ever, that the cross-sectional nature of our study is limit-
ing our ability to understand the complex relationship
between anxiety, depression, type D personality and their
impact on the development of the MetS.
Future perspective
In this cross-sectional study we identified a type of per-
sonality, characterized by increased emotional distress
and avoidance of social contacts, as a strong and inde-
pendent predictor of the MetS. Since the MetS serves as
a prodromal stage in the development of atherosclerotic
vascular disease, it would be interesting to study
whether modification of these personality characteristics
could reduce the risk for the progression of athero-
sclerotic vascular disease giving an opportunity for pri-
mary prevention. Future studies should aim to explore
this possibility.
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